- Price Band is fixed at ₹75 to ₹79 per Equity Share of face value of ₹5 each.
- The Anchor Investor Bidding Date will open and close on Thursday, February 19, 2026.
- The Offer opens on Friday, February 20, 2026, for Bids and closes on Tuesday, February 24, 2026.
- Bids can be made for a minimum of 189 Equity Shares and in multiples of 189 Equity Shares thereafter
NE BUSINESS BUREAU
AHMEDABAD, FEB 19
Fertility services provider Gaudium IVF and Women Health Limited on Wednesday announced that the Bid / Offer Opening Date in relation to its initial public offer of the Equity Shares will be Friday, February 20, 2026.
The Offer comprises a fresh issue of such number of Equity Shares by the Company aggregating up to 1,13,92,500 Equity Shares and an offer for sale of up to 94,93,700 Equity Shares by Dr. Manika Khanna, promoter selling shareholder.
With this, it will become the first company in the sector to tap the public markets.
Proceeds from the fresh issue are intended for capital expenditure of ₹50 crore to establish 19 new IVF centres across India, including Surat and Ahmedabad in Gujrata, along with repayment or pre-payment of certain borrowings of ₹20 crore, and for general corporate purposes.
The Anchor Investor Bid/Offer Period opens and closes on Thursday, February 19, 2026. The Bid/Offer Period will open on Friday, February 20, 2026 for subscription and close on Tuesday, February 24, 2026.
The Price Band of the Offer has been fixed at ₹75 to ₹79 per Equity Share. Bids can be made for a minimum of 189 Equity Shares and in multiples of 189 Equity Shares thereafter.
Financially, the company reported revenue from operations of ₹70.72 crore and a profit after tax (PAT) of ₹19.13 crore for the financial year ending March 31, 2025. In FY24, revenue was ₹47.89 crore, with a PAT of ₹10.31 crore.
Founded by Dr Manika Khanna, Gaudium IVF has established itself as a pioneer in assisted reproductive technologies in India. The company operates through a ‘hub-and-spoke’ model, with seven hubs and 28 spokes across multiple states, enabling it to reach a wide patient base.
Dr. Manika Khanna completed her MBBS and MD in Obstetrics & Gynaecology from Medical College, Baroda, in 1996 and 1998, respectively.
According to Infomerics Research report, the broader Indian IVF market is projected to grow at a CAGR of 13 per cent expanding from $1.32 billion in 2024 to $4.54 billion by 2034, presenting significant growth potential for established players like Gaudium IVF.
The Equity Shares to be offered through the RHP are proposed to be listed on the Main Board of BSE Limited and National Stock Exchange of India Limited. For the purposes of the Offer, NSE is the Designated Stock Exchange.
Sarthi Capital Advisors has been appointed as the sole book running Lead manager for the issue, while Bigshare Services will serve as the registrar.
